Michael Hinds

Statistics

Publications

Citations

705

H-Index

Active since

1982

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas at Austin

Michael Hinds is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, topoisomerase ii function, and dna topoisomerase ii inhibition.

Publications per year

1982–1992

Publications

Characterization of an Amsacrine-resistant Line of Human Leukemia Cells

Leonard A. Zwelling, Michael Hinds, Diana Chan et al. · Journal of Biological Chemistry · 1989 · 179 citations · Full text

Medicine, Oncology, Pharmacology +12

Identification of a point mutation in the topoisomerase II gene from a human leukemia cell line containing an amsacrine-resistant form of topoisomerase II.

Michael Hinds, Karl Deisseroth, Janice Mayes et al. · PubMed · 1991 · 152 citations

Medicine, Molecular Biology, Oncology +13

Properties of R1162, a broad-host-range, high-copy-number plasmid

R J Meyer, Michael Hinds, Michael A. Brasch · Journal of Bacteriology · 1982 · 66 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

HT1080/DR4: A P-Glycoprotein-Negative Human Fibrosarcoma Cell Line Exhibiting Resistance to Topoisomerase II-Reactive Drugs Despite the Presence of a Drug-Sensitive Topoisomerase II

Leonard A. Zwelling, Marilyn L. Slovak, J. H. Doroshow et al. · JNCI Journal of the National Cancer Institute · 1990 · 58 citations

Medicine, Oncology, Pharmacology +17

Multiple mechanisms for expression of incompatibility by broad-host-range plasmid RK2

R J Meyer, Michael Hinds · Journal of Bacteriology · 1982 · 49 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

1–5 of 12